Genezen News & Resources

Keep up to date with the latest news at Genezen, and explore our expert content around molecular biology news and insights.

Scroll Down

Filter

By type

By service

Premium content

Genezen appoints Chief Commercial Officer to…

  Genezen, a cell and gene therapy Contract Development and Manufacturing...

Read more

Downstream Process Development for Lentiviral Vectors…

Lentiviral vectors (LVV) are commonly used as an efficient and safe...

Read more

Stable cell lines vs transient transfection…

The aim of upstream processing in viral vector development and manufacturing...

Read more

Genezen delivers next phase of cGMP…

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization...

Read more

Genezen, Monon Bioventures, and Purdue University…

Glioblastoma is one of the most aggressive types of cancer, affecting...

Read more

How can pseudotyping gammaretrovirus impact manufacturing?

Designing the plasmids that will be transfected into producer cells in...

Read more
Load more

Get insights like this directly to your inbox

Sign up to our newsletter

Our solutions

From Process Development, Testing, GMP Vector Manufacturing to Cell Manufacturing

Our team offers the guidance, expertise, technology, and manufacturing capacity to help bring your viral vector therapy to market with precision and speed.